;PMID: 2326830
;source_file_650.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..31] = [t:0..31]
;1)sentence:[e:37..117] = [t:37..117]
;2)section:[e:121..156] = [t:121..156]
;3)section:[e:160..248] = [t:160..248]
;4)sentence:[e:252..555] = [t:252..555]
;5)sentence:[e:556..736] = [t:556..736]
;6)sentence:[e:737..896] = [t:737..896]
;7)sentence:[e:897..1126] = [t:897..1126]
;8)sentence:[e:1127..1197] = [t:1127..1197]
;9)section:[e:1201..1245] = [t:1201..1245]

;section 0 Span:0..31
;Steroids. 1990 Feb;55(2):69-73.
(SEC
  (FRAG (NNP:[0..8] Steroids) (,:[8..9] .) (CD:[10..14] 1990)
        (CC:[15..22] Feb;55-LRB-) (CD:[22..23] 2) (-RRB-:[23..24] -RRB-)
        (CD:[24..27] :69) (::[27..28] -) (CD:[28..30] 73) (.:[30..31] .)))

;sentence 1 Span:37..117
;Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian
;homogenates.
;[37..46]:cyp450:"Aromatase"
;[61..69]:substance:"R 76 713"
;[105..116]:substance:"homogenates"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[37..46] Aromatase) (NN:[47..57] inhibition))
      (PP (IN:[58..60] by)
        (NP (NN:[61..69] R-SP-76-SP-713))))
    (::[69..70] :)
    (NP
      (NP (DT:[71..72] a) (JJ:[73..80] kinetic) (NN:[81..89] analysis))
      (PP-LOC (IN:[90..92] in)
        (NP (NN:[93..96] rat) (JJ:[97..104] ovarian)
            (NNS:[105..116] homogenates))))
    (.:[116..117] .)))

;section 2 Span:121..156
;Krekels MD, Wouters W, De Coster R.
(SEC
  (FRAG (NNP:[121..128] Krekels) (NNP:[129..131] MD) (,:[131..132] ,)
        (NNP:[133..140] Wouters) (NNP:[141..142] W) (,:[142..143] ,)
        (NNP:[144..146] De) (NNP:[147..153] Coster) (NNP:[154..156] R.)))

;section 3 Span:160..248
;Department of Endocrinology and Oncology, Janssen Research Foundation,
;Beerse,  Belgium.
(SEC
  (FRAG (NNP:[160..170] Department) (IN:[171..173] of)
        (NNP:[174..187] Endocrinology) (CC:[188..191] and)
        (NNP:[192..200] Oncology) (,:[200..201] ,) (NNP:[202..209] Janssen)
        (NNP:[210..218] Research) (NNP:[219..229] Foundation) (,:[229..230] ,)
        (NNP:[231..237] Beerse) (,:[237..238] ,) (NNP:[240..247] Belgium)
        (.:[247..248] .)))

;sentence 4 Span:252..555
;Reaction kinetics of the aromatase enzyme and of a new nonsteroidal aromatase
; inhibitor, R 76 713 
;(6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)-methyl]-1-methyl-1H-
;benzotriazole),  were studied in ovarian homogenates obtained from pregnant
;mare's serum  gonadotropin (PMSG)-injected female Wistar rats.
;[277..293]:cyp450:"aromatase enzyme"
;[320..329]:cyp450:"aromatase"
;[331..340]:substance:"inhibitor"
;[342..350]:substance:"R 76 713"
;[353..430]:substance:"6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)-methyl]-1-me
;thyl-1H- benzotriazole"
;[458..469]:substance:"homogenates"
;[484..519]:substance:"pregnant mare's serum  gonadotropin"
;[521..525]:substance:"PMSG"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[252..260] Reaction) (NNS:[261..269] kinetics))
      (PP
        (PP (IN:[270..272] of)
          (NP (DT:[273..276] the)
             (NN:[277..286] aromatase) (NN:[287..293] enzyme)))
        (CC:[294..297] and)
        (PP (IN:[298..300] of)
          (NP
            (NP (DT:[301..302] a) (JJ:[303..306] new)
                (JJ:[307..319] nonsteroidal) (NN:[320..329] aromatase)
                (NN:[331..340] inhibitor))
            (,:[340..341] ,)
            (NP
              (NP (NN:[342..350] R-SP-76-SP-713))
              (NP (-LRB-:[352..353] -LRB-)
                
                 (NN:[353..416] 6--LSB--LRB-4-chlorophenyl-RRB--LRB-1H-1,2,4-triazol-1-yl-RRB--methyl-RSB--1-methyl-1H-)
                 (NN:[417..430] benzotriazole)
                (-RRB-:[430..431] -RRB-)))))))
    (,:[431..432] ,)
    (VP (VBD:[434..438] were)
      (VP (VBN:[439..446] studied)
        (NP-1 (-NONE-:[446..446] *))
        (PP-LOC (IN:[447..449] in)
          (NP
            (NP (JJ:[450..457] ovarian) (NNS:[458..469] homogenates))
            (VP (VBD:[470..478] obtained)
              (NP (-NONE-:[478..478] *))
              (PP (IN:[479..483] from)
                (NP
                  (ADJP
                    (NML
                      (NML
                        (NP (JJ:[484..492] pregnant) (NN:[493..497] mare)
                            (POS:[497..499] 's))
                        (NN:[500..505] serum) (NN:[507..519] gonadotropin))
                      (NML (-LRB-:[520..521] -LRB-) (NN:[521..525] PMSG)
                           (-RRB-:[525..526] -RRB-)))
                    (HYPH:[526..527] -) (VBN:[527..535] injected))
                  (JJ:[536..542] female) (NNP:[543..549] Wistar)
                   (NNS:[550..554] rats))))))))
    (.:[554..555] .)))

;sentence 5 Span:556..736
;The Km (Michaelis constant) of  the aromatase enzyme with androstenedione as
;the substrate was 47 +/- 13 nM; for  testosterone as the substrate, a value
;of 159 +/- 10 nM was found.
;[560..562]:quantitative-name:"Km"
;[564..582]:quantitative-name:"Michaelis constant"
;[592..608]:cyp450:"aromatase enzyme"
;[614..629]:substance:"androstenedione"
;[637..646]:substance:"substrate"
;[651..660]:quantitative-value:"47 +/- 13"
;[661..663]:quantitative-units:"nM"
;[670..682]:substance:"testosterone"
;[690..699]:substance:"substrate"
;[712..722]:quantitative-value:"159 +/- 10"
;[723..725]:quantitative-units:"nM"
(SENT
  (S
    (S
      (NP-SBJ
        (NP
          (NP (DT:[556..559] The) (NN:[560..562] Km))
          (NP (-LRB-:[563..564] -LRB-)
             (NNP:[564..573] Michaelis) (NN:[574..582] constant)
            (-RRB-:[582..583] -RRB-)))
        (PP (IN:[584..586] of)
          (NP
            (NP (DT:[588..591] the)
               (NN:[592..601] aromatase) (NN:[602..608] enzyme))
            (PP (IN:[609..613] with)
              (NP
                (NP (NN:[614..629] androstenedione))
                (PP (IN:[630..632] as)
                  (NP (DT:[633..636] the) (NN:[637..646] substrate))))))))
      (VP (VBD:[647..650] was)
        (NP-PRD
          (QP (CD:[651..653] 47) (SYM:[654..657] +/-) (CD:[658..660] 13))
          (NN:[661..663] nM))))
    (::[663..664] ;)
    (S
      (PP (IN:[665..668] for)
        (NP
          (NP (NN:[670..682] testosterone))
          (PP (IN:[683..685] as)
            (NP (DT:[686..689] the) (NN:[690..699] substrate)))))
      (,:[699..700] ,)
      (NP-SBJ-1
        (NP (DT:[701..702] a) (NN:[703..708] value))
        (PP (IN:[709..711] of)
          (NP
            (QP (CD:[712..715] 159) (SYM:[716..719] +/-) (CD:[720..722] 10))
            (NN:[723..725] nM))))
      (VP (VBD:[726..729] was)
        (VP (VBN:[730..735] found)
          (NP-1 (-NONE-:[735..735] *)))))
    (.:[735..736] .)))

;sentence 6 Span:737..896
;In the  presence of increasing concentrations of R 76 713, the Km increased
;while the  Vmax (maximal velocity of enzyme-catalyzed reaction) remained
;unchanged.
;[786..794]:substance:"R 76 713"
;[800..802]:quantitative-name:"Km"
;[824..828]:quantitative-name:"Vmax"
;[830..846]:quantitative-name:"maximal velocity"
;[850..856]:substance:"enzyme"
(SENT
  (S
    (PP (IN:[737..739] In)
      (NP
        (NP (DT:[740..743] the) (NN:[745..753] presence))
        (PP (IN:[754..756] of)
          (NP
            (NP (VBG:[757..767] increasing) (NNS:[768..782] concentrations))
            (PP (IN:[783..785] of)
              (NP (NN:[786..794] R-SP-76-SP-713)))))))
    (,:[794..795] ,)
    (NP-SBJ (DT:[796..799] the) (NN:[800..802] Km))
    (VP (VBD:[803..812] increased)
      (SBAR-ADV (IN:[813..818] while)
        (S
          (NP-SBJ
            (NP (DT:[819..822] the) (NN:[824..828] Vmax))
            (NP (-LRB-:[829..830] -LRB-)
              (NP (JJ:[830..837] maximal) (NN:[838..846] velocity))
              (PP (IN:[847..849] of)
                (NP
                  (ADJP (NN:[850..856] enzyme) (HYPH:[856..857] -)
                        (VBN:[857..866] catalyzed))
                  (NN:[867..875] reaction)))
              (-RRB-:[875..876] -RRB-)))
          (VP (VBD:[877..885] remained)
            (ADJP-PRD (JJ:[886..895] unchanged))))))
    (.:[895..896] .)))

;sentence 7 Span:897..1126
;Using  androstenedione and testosterone as the substrate, Lineweaver-Burk
;analysis of  the data showed a Ki (dissociation constant of the
;enzyme-inhibitor complex) for  R 76 713 of 0.7 +/- 0.3 nM and 1.6 +/- 0.4 nM,
;respectively.
;[904..919]:substance:"androstenedione"
;[924..936]:substance:"testosterone"
;[944..953]:substance:"substrate"
;[1002..1004]:quantitative-name:"Ki"
;[1006..1027]:quantitative-name:"dissociation constant"
;[1035..1059]:substance:"enzyme-inhibitor complex"
;[1066..1074]:substance:"R 76 713"
;[1078..1089]:quantitative-value:"0.7 +/- 0.3"
;[1090..1092]:quantitative-units:"nM"
;[1097..1108]:quantitative-value:"1.6 +/- 0.4"
;[1109..1111]:quantitative-units:"nM"
(SENT
  (S
    (S-MNR
      (NP-SBJ (-NONE-:[897..897] *))
      (VP (VBG:[897..902] Using)
        (NP (NN:[904..919] androstenedione) (CC:[920..923] and)
            (NN:[924..936] testosterone))
        (PP (IN:[937..939] as)
          (NP (DT:[940..943] the) (NN:[944..953] substrate)))))
    (,:[953..954] ,)
    (NP-SBJ
      (NP
        (NML (NNP:[955..965] Lineweaver) (HYPH:[965..966] -)
             (NNP:[966..970] Burk))
        (NN:[971..979] analysis))
      (PP (IN:[980..982] of)
        (NP (DT:[984..987] the) (NN:[988..992] data))))
    (VP (VBD:[993..999] showed)
      (NP
        (NP
          (NP (DT:[1000..1001] a) (NN:[1002..1004] Ki))
          (NP (-LRB-:[1005..1006] -LRB-)
            (NP (NN:[1006..1018] dissociation) (NN:[1019..1027] constant))
            (PP (IN:[1028..1030] of)
              (NP (DT:[1031..1034] the)
                
                (ADJP (NN:[1035..1041] enzyme) (HYPH:[1041..1042] -)
                      (NN:[1042..1051] inhibitor))
                (NN:[1052..1059] complex)))
            (-RRB-:[1059..1060] -RRB-)))
        (PP (IN:[1061..1064] for)
          (NP (NN:[1066..1074] R-SP-76-SP-713)))
        (PP (IN:[1075..1077] of)
          (NP
            (NP
              (QP (CD:[1078..1081] 0.7) (SYM:[1082..1085] +/-)
                  (CD:[1086..1089] 0.3))
              (NN:[1090..1092] nM))
            (CC:[1093..1096] and)
            (NP
              (QP (CD:[1097..1100] 1.6) (SYM:[1101..1104] +/-)
                  (CD:[1105..1108] 0.4))
              (NN:[1109..1111] nM)))))
      (,:[1111..1112] ,)
      (ADVP (RB:[1113..1125] respectively)))
    (.:[1125..1126] .)))

;sentence 8 Span:1127..1197
;R 76 713 appeared  to competitively inhibit the rat ovarian aromatase.
;[1127..1135]:substance:"R 76 713"
;[1187..1196]:cyp450:"aromatase"
(SENT
  (S
    (NP-SBJ-1 (NN:[1127..1135] R-SP-76-SP-713))
    (VP (VBD:[1136..1144] appeared)
      (S
        (NP-SBJ-1 (-NONE-:[1144..1144] *))
        (VP (TO:[1146..1148] to)
          (ADVP (RB:[1149..1162] competitively))
          (VP (VB:[1163..1170] inhibit)
            (NP (DT:[1171..1174] the) (NN:[1175..1178] rat)
                (JJ:[1179..1186] ovarian) (NN:[1187..1196] aromatase))))))
    (.:[1196..1197] .)))

;section 9 Span:1201..1245
;PMID: 2326830 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1201..1205] PMID) (::[1205..1206] :) (CD:[1207..1214] 2326830)
        (NN:[1215..1216] -LSB-) (NNP:[1216..1222] PubMed) (::[1223..1224] -)
        (NN:[1225..1232] indexed) (IN:[1233..1236] for)
        (NNP:[1237..1245] MEDLINE-RSB-)))
